AMICUS THERAPEUTICS INC. - COMMON STOCK

Amicus Therapeutics Announces Presentations and Posters at the 18th Annual WORLDSymposium™ 2022

07 2 2022 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance

10 1 2022 07:00:02 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

05 1 2022 07:00:01 提供 Nasdaq GlobeNewswire

European Medicines Agency Validates Amicus Therapeutics Marketing Authorization Applications for AT-GAA for the Treatment of Pompe Disease

03 12 2021 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the 4th Annual Evercore ISI HealthCONx Virtual Conference

24 11 2021 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Presentations at the 14th International Congress of Inborn Errors of Metabolism

22 11 2021 07:00:00 提供 Nasdaq GlobeNewswire

The Lancet Neurology Publishes Pivotal Phase 3 PROPEL Study Results of AT-GAA in Late-Onset Pompe Disease

18 11 2021 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Stifel 2021 Virtual Healthcare Conference

11 11 2021 07:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Third Quarter 2021 Financial Results and Corporate Updates

09 11 2021 07:00:04 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Third Quarter 2021 Financial Results on November 9, 2021

03 11 2021 07:00:01 提供 Nasdaq GlobeNewswire

U.S. FDA Accepts Filings for Amicus’ AT-GAA for the Treatment of Pompe Disease

29 9 2021 06:30:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”

29 9 2021 06:30:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Presentations at the 26th International Annual Congress of the World Muscle Society

20 9 2021 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2021

03 9 2021 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fabry Disease

02 8 2021 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021

27 7 2021 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Appoints Eiry W. Roberts, M.D. to its Board of Directors

14 6 2021 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

28 5 2021 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Upcoming Presentations at the 16th International Congress on Neuromuscular Diseases

21 5 2021 07:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates

10 5 2021 07:00:00 提供 Nasdaq GlobeNewswire